Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Marine viaduct to be built to link southern Penang with Silicon Island | ||
Fr | Appellate court to hear Anwar's bid to pause sexual assault civil trial next week | ||
Fr | Video clip case: MACC concludes probe on Sabah assemblyman's alleged corruption | ||
Fr | Pakistan hopes to advance Asean partnership status - envoy | ||
Fr | FBM KLCI down 0.09% to 1,516.79 on June 6, 2025 | ||
Fr | Anwar to contact Thai PM over Thailand-Cambodia border dispute | ||
Fr | Malaysian govt demands telcos hand over detailed phone records, internet usage data - report | ||
Fr | Asian currencies poised for weekly gains; rate cut lifts Indian equities | ||
Fr | Petronas job cuts to mainly affect contract staff, says PM | ||
Fr | JPJ opens investigation paper against lorry firm in FRU fatal crash | ||
Fr | Pernas announces Mohamed Rozhan Mohd Ghazalli as new independant non-exec chairman | ||
Fr | Bank Islam CFO Azizan Abd Aziz leaves to become CFO of Bursa Malaysia | ||
Fr | Stocks with momentum on June 6, 2025: Agmo, Country Heights, Sungei Bagan Rubber Company (Malaya), Rex Industry | ||
Fr | UOB Kay Hian cuts earnings, keeps FBM KLCI target at 1,620 on 2H2025 recovery hopes | ||
Fr | Yinson shares surge to five-month high following report of potential buyout | ||
Fr | Cleanroom builder iCents targets July listing on ACE Market | ||
Fr | Stonepeak said in exclusive talks for buyout of US$2.1b Yinson - Bloomberg | ||
Fr | Pavilion REIT prices private placement at RM1.40 apiece to raise some RM360m | ||
Fr | Sarawak reaffirms stand as Southeast Asia's clean energy leader at UK conference | ||
Fr | UEM Sunrise sees 34% take-up for Cyberjaya project on launch day | ||
Fr | Singapore-based ChemOne seeks over US$2.7b loan for Pengerang chemical plant in Johor - Bloomberg | ||
Fr | Kenanga downgrades auto sector to 'neutral' amid intensifying competition from foreign brands, subsidy risks | ||
Fr | Malaysia exempts job contracts signed before 2025 from stamp duty | ||
Fr | Econpile's earnings to rebound in 4Q; analysts expect more contract wins | ||
Fr | Duopharma's sales to public sector could moderate in coming months, Kenanga says |